PCSA icon

Processa Pharmaceuticals

12 hedge funds and large institutions have $75.9K invested in Processa Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
12
Holders Change
+3
Holders Change %
+33.33%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
4
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
VF
1
Virtu Financial
New York
$21K 104,723 +61,494 +142%
UBS Group
2
UBS Group
Switzerland
$13.2K 64,612 +64,556 +115,279%
AGM
3
Alpine Global Management
New York
$11K 53,416 +53,416 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$10.4K 50,573 +16,160 +47%
CSS
5
Cubist Systematic Strategies
Connecticut
$8.58K 41,848 +41,848 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$5.01K 24,433
Jane Street
7
Jane Street
New York
$3.95K 19,270 +19,270 New
SFA
8
Sequoia Financial Advisors
Ohio
$2.26K 11,000 +11,000 New
TRCT
9
Tower Research Capital (TRC)
New York
$505 2,462 -5 -0.2%
Wells Fargo
10
Wells Fargo
California
$32 154
Bank of America
11
Bank of America
North Carolina
$22 108 +71 +192%
SS
12
SBI Securities
Japan
$2 12 +12 New
AC
13
Armistice Capital
New York
-56,000 Closed
MMA
14
Miracle Mile Advisors
California
-10,000 Closed